COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

THE FOUNDATION FOR REPRODUCTIVE MEDICINE INC

NEW YORK, NY · EIN 814615550 · Form 990 · FY2024 · NTEE H40 · Medical Research · Small ($100K-$1M) · foundationforreprodmed.com
revenue
$337K
expenses
$367K
net assets
$1K
employees
1
program ratio
95%
mission · from form 990

TO ORGANIZE, COORDINATE, AND OFFER RESEARCH FACILITIES IN THE AREA OF REPRODUCTIVE MEDICINE.

profile · synthesized from sources

The Foundation for Reproductive Medicine is a New York-based nonprofit focused on advancing research and medical education in reproductive medicine. It supports original research in reproductive biology and clinical infertility, funds scientific investigations, and organizes continuing medical education events, including an annual international conference. The foundation emphasizes dissemination of knowledge and challenges prevailing practices in reproductive medicine through evidence-based discourse.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $312K
    EDUCATIONAL CONFERENCES AND SEMINARS PROVIDED
named programs · 3 · from sources

What they call their work

FRMC Annual Conference
Three-day CME and CEU-accredited conference featuring lectures, roundtables, and presentations by global experts on advances in fertility and reproductive medicine.
Reproductive Medicine GrandRounds
Monthly continuing medical education series co-sponsored with the Center for Human Reproduction, offering up-to-date scientific presentations for physicians and scientists.
Research Grants Program
Provides funding to investigators conducting research in reproductive biology and clinical medicine, with emphasis on innovative and clinically applicable projects.
activities · 5 groups

What they do

  • Infertility Support and Assisted Reproductive Services 1 activity
    • Conducts and publishes original research in reproductive endocrinology and infertility
      Supports and conducts research that has led to the development and global dissemination of innovative infertility treatments. Specific studies include investigations into oocyte morphology in non-PCOS patients undergoing ICSI, critiques of PGT-A efficacy, and the first reported healthy euploid birth following transfer of embryos previously classified as abnormal by PGT-A.
  • Medical Research Funding 1 activity
    • Funds research in reproductive medicine and biology
      Awards research grants and monetary prizes ($1,000, $500, $250) to investigators for projects with clinical applicability in reproductive medicine, including studies on oocyte maturation, endometrial receptivity, and fetal-maternal communication. Complimentary conference registration is also provided to winners.
  • Medical Professional Education & Training 1 activity
    • Hosts continuing medical education (CME) events in reproductive medicine
      Organizes monthly GrandRounds lectures and an annual 3-day CME/CE-accredited conference in New York City, featuring expert presentations and scientific discussions for clinicians and scientists in reproductive medicine. The monthly series runs during the academic year and includes guest speakers such as Dr. Alan DeCherney.
  • Scientific Conference & Symposium Management 1 activity
    • Organizes the annual Foundation for Reproductive Medicine Conference (FRMC)
      Hosts a major annual conference in New York City that draws over 100 reproductive endocrinologists, laboratory directors, and scientists globally to discuss new findings in fertility, including topics such as PGT-A, AI in fertility, and obesity-related infertility. The event includes abstract presentations and expert-led sessions.
  • Uncategorized 1 activity
    • Provides educational programming and access to reproductive medicine professionals
      Offers reduced ticket prices and opportunities for program input to registered attendees of the FRMC event, and accepts abstract submissions for presentation at the FRMC 2026 conference focused on reproductive biology and reproductive endocrinology and infertility.
financials · form 990 · fy2024
revenue
Total revenue$337K
Contributions & grants$226K67%
Program service revenue$112K33%
Investment income$00%
Other revenue$0
expenses
Total expenses$367K
Program expenses95%
Admin / overhead5%
Fundraising0%
Salaries & benefits$69K
Grants paid out$0
Largest expense lineCompensation
balance sheet
Total assets$10K
Cash$7K
Investments$0
Liabilities$9K
Net assets$1K
Liquid reserves0.2 mo
4 years on record · 2020–2024 · YoY revenue +17.6%
leadership · form 990 part vii · fy2024

Who runs it

board members · 4
  • DAVID H BARAD — TRESURER/DIRECTOR
  • DWYN HAREN — VICE CHAIR/DIRECTOR
  • JOLANTA TAPPER — SECRETARY/DIRECTOR
  • NORBERT GLEICHER — PRESIDEN/DIRECTOR
relationships · 18

Who they work with

  • AOM Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • ASRM Network — Follows ASRM abstract specifications for submissions.
  • ASRM Partner — Engages with ASRM through commentary and critique of its practice committee opinions on PGT-A.
  • Center For Human Reproduction Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • Center for Human Reproduction Partner — Co-sponsors monthly Reproductive Medicine GrandRounds in New York City.
  • Center for Human Reproduction Partner — Co-sponsors the GrandRounds CME lecture series with FRM.
  • Ferring Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • Fertilis Partner — Dr. Lister Salgueiro, a presenter of research supported by the Foundation, is affiliated with Fertilis, indicating a professional relationship through research presentation.
  • IVFSTORE Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • International Do No Harm Group in IVF (IDNHG-IVF) Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • Medical Electronic Systems Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • Metropolitan Club Partner — Venue partner for hosting the FRMC conference.
  • Ovaterra Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • SART Partner — Engages with SART through commentary and critique of its practice committee opinions on PGT-A.
  • The Center for Human Reproduction Partner — Collaborates with the Foundation for Reproductive Medicine, as indicated by co-branding and shared programming.
  • The Reproductive Times Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • ViaCord Partner — Corporate sponsor of the Foundation for Reproductive Medicine's annual conference.
  • Whova Partner — Uses Whova as its official event registration platform.
strategies · 4

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Critical Evaluation of Established Technologies
    methodology: critical_evaluation_of_technologies
    By independently researching and challenging the efficacy of established reproductive technologies like PGT-A, the foundation improves patient outcomes because identifying harmful or ineffective practices prevents their widespread adoption and redirects clinical focus toward evidence-based care.
  • Multi-Format Continuing Medical Education
    methodology: continuing_medical_education
    By delivering cutting-edge research through lectures, roundtables, and Q&As, the foundation advances clinical practice because interactive, multi-format education increases knowledge retention and encourages critical engagement among medical professionals.
  • Open-Science Research Funding
    methodology: open_science_research_funding
    By funding research with the requirement that findings be publicly shared, the foundation accelerates global knowledge advancement in reproductive medicine because open access enables broader scientific validation, collaboration, and faster translation into clinical practice.
  • Research Recognition and Dissemination
    methodology: research_recognition
    By recognizing and showcasing high-quality research through abstract submissions, the foundation stimulates innovation and rigor in reproductive medicine because public recognition incentivizes researchers to produce clinically relevant, high-quality work.